Stage IIIA Skin Melanoma Recruiting Phase 1 Trials for Dabrafenib (DB08912)

IndicationStatusPhase
DBCOND0029533 (Stage IIIA Skin Melanoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs